Targeting key proximal drivers of type 2 inflammation in disease
Year: 2015
Type: review
Source: Nature Reviews Drug Discovery
DOI: 10.1038/nrd4624
Institutions: Regeneron (United States), Sanofi (United States)
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Regeneron Pharmaceuticals
OpenAlex ID: W2200308911
